Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02MLO
|
|||
| Former ID |
DIB000599
|
|||
| Drug Name |
WT1-targeted autologous dendritic cell vaccine
|
|||
| Synonyms |
WT1-targeted autologous dendritic cell vaccine (cancer)
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Acute myeloid leukaemia [ICD-11: 2A60] | Phase 2 | [1] | |
| Company |
University of Antwerp; Argos Therapeutics Durham; NC Geron; Dendreon Seattle; WA; ImmunoCellular Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Wilms tumor protein (WT1) | Target Info | . | [1] |
| KEGG Pathway | Transcriptional misregulation in cancer | |||
| NetPath Pathway | FSH Signaling Pathway | |||
| IL5 Signaling Pathway | ||||
| Pathway Interaction Database | p73 transcription factor network | |||
| Regulation of Telomerase | ||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | |||
| Integrated Pancreatic Cancer Pathway | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01686334) Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.